Song Min-ning, Song Yu-na, Chen Fu, Luo Mei-lan
Department of Infectious Diseases, the 174 th Hospital of PLA, Xiamen 361003, Fujian, China.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Jan;19(1):50-2.
To investigate the changes in serotonin (5-HT) and noradrenaline (NA) in hepatic encephalopathy as a result of acute and chronic liver failure in rat.
One hundred and ten Sprague-Dawley (SD) rats were randomly divided into groups of normal control (n=20), experimental group of acute liver failure (ALF) encephalopathy (n=45), and experimental group of chronic liver failure (CLF) encephalopathy (n=45). Two dosages of thioacetamide (TAA) of 500 mg/kg were gavaged with an interval of 24 hours to reproduce ALF model. To reproduce CLF model rats were fed with 0.03% TAA in drinking water for 10 weeks, and 50% of TAA dosage was added or withheld according to the change in weekly body weight measurement. Animals were sacrificed and venous blood specimens were obtained after successful replication of model, and 5-HT, NA, ammonia, parameters of liver function were determined, and liver and brain were studied pathologically.
The experiment showed that the liver functions of rats in groups ALF encephalopathy and CLF encephalopathy deteriorated seriously, changes in alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), albumen (ALB), ALB/globulin (A/G), and blood ammonia were observed(P<0.05 or P<0.01). The clinical manifestations, liver and brain pathologies were identical to those of ALF and CLF encephalopathy. The values of 5-HT were increased in groups ALF encephalopathy and CLF encephalopathy [(16.06+/-1.08) micromol/L and (15.32+/-1.48) micromol/L] compared with the normal group [(2.75+/-0.26) micromol/L, both P<0.01], while the value of NA decreased in the group of CLF encephalopathy [(94.0+/-2.13) pmol/L vs.(121.2+/-14.8) pmol/L,P<0.05].
The levels of 5-HT are elevated in the groups of ALF encephalopathy and CLF encephalopathy. The content of NA decreases remarkably in CLF encephalopathy.
研究大鼠急性和慢性肝衰竭所致肝性脑病中血清素(5-羟色胺,5-HT)和去甲肾上腺素(NA)的变化。
110只Sprague-Dawley(SD)大鼠随机分为正常对照组(n = 20)、急性肝衰竭(ALF)脑病实验组(n = 45)和慢性肝衰竭(CLF)脑病实验组(n = 45)。以500 mg/kg的两种剂量硫代乙酰胺(TAA)间隔24小时灌胃以复制ALF模型。为复制CLF模型,大鼠饮用含0.03% TAA的水10周,并根据每周体重测量结果增减50%的TAA剂量。模型成功复制后处死动物并采集静脉血标本,测定5-HT、NA、氨及肝功能参数,并对肝脏和脑进行病理研究。
实验显示,ALF脑病组和CLF脑病组大鼠肝功能严重恶化,观察到丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、总胆红素(TBIL)、白蛋白(ALB)、ALB/球蛋白(A/G)及血氨的变化(P < 0.05或P < 0.01)。临床表现、肝脏和脑病理学与ALF和CLF脑病相符。与正常组[(2.75±0.26)μmol/L,P均< 0.01]相比,ALF脑病组和CLF脑病组的5-HT值升高[分别为(16.06±1.08)μmol/L和(15.32±1.48)μmol/L],而CLF脑病组的NA值降低[(94.0±2.13)pmol/L对(121.2±14.8)pmol/L,P < 0.05]。
ALF脑病组和CLF脑病组的5-HT水平升高。CLF脑病中NA含量显著降低。